Summary The single-cell gel electrophoresis (comet) assay was used to measure radiation-produced DNA double-strand breaks (dsbs) in a series of seven cervical tumour cell lines (ME180, HT3, C33A, C41, SiHa, MS751 and CaSki). The proportion of DNA dsbs was measured immediately after radiation treatment (initial damage) and 16 h later after incubation at 370C (residual damage). Linear dose-response curves were seen for initial (slopes 0.23-0.66) and residual (slopes 0.16-0.87) DNA dsbs. Neither of the slopes of the linear regression analysis on the initial and on the residual DNA dsbs dose-response curves (range 0-80 Gy) correlated with SF2 (surviving fraction at 2 Gy) measured after high-(HDR) or low-dose-rate (LDR) irradiation. An association was evident between SF2 after HDR and LDR irradiation and the ratio of the absolute level of initial and residual damage after a single dose of 60 Gy. However, a significant correlation was found between HDR (r= -0.78, P = 0.04) and LDR (r = -0.86, P = 0.03) SF2 values and the ratio of the slopes of the initial and residual DNA dsbs dose-response curves (range 0.47-0.99), representing the fraction of DNA damage remaining. These results indicate that the neutral comet assay can be used to predict radiosensitivity of cervical tumour cell lines by assessing the ratio of initial and residual DNA dsbs.
The variation in cellular radiosensitivity of human fibroblasts measured in vitro can be explained largely by the extent of DNA double-strand break (dsb) repair (Wurm et al, 1994; Kiltie et al, 1997) . However, for tumour cells, no firm consensus exists for a correlation between in vitro radiosensitivity and the magnitude of radiation-induced DNA dsb damage or repair. A number of reports indicate that tumour cell radiosensitivity is positively correlated with the levels of initial radiation-induced DNA dsbs (Kelland et al, 1988; Peacock et al, 1989; McMillan et al, 1990; Ruiz de Almodovar et al, 1994) , while others have shown no correlation (Smeets et al, 1993; Olive et al, 1994; McKay and Kefford, 1995) . Positive correlations between tumour cell radiosensitivity and the extent of residual DNA dsbs (Giaccia et al, 1992; Zaffaroni et al, 1994) , the rate of DNA dsb repair (Schwartz et al, 1988) and the misrepair of radiation-induced DNA damage (Powell et al, 1992; Powell and McMillan, 1994) have also been reported.
The aim of this study was to measure the level of initial and residual radiation-induced DNA dsbs in seven cervical carcinoma cell lines of differing radiosensitivity, as assessed by clonogenic survival after high-(HDR) and low-dose-rate (LDR) irradiation to evaluate the potential of the neutral comet assay as a predictor of radiosensitivity. This method of measuring DNA dsbs was used as it is rapid (Olive et al, 1991; Fairbaim et al, 1995) , is less technically demanding than other assays (e.g. neutral filter elution and pulse field gel electrophoresis) and does not require the use of pretreatment radiolabelling to quantify DNA dsb damage,
The seven cervical carcinoma cell lines used in these studies (CaSki, SiHa, ME180, HT3, C41, C33 and MS751) were obtained originally from the American Type Culture Collection (ATCC). All cells were grown in minimum essential medium (MEM), supplemented with L-glutamine (2 mM), penicillin (100 IU ml-'), streptomycin (0.1 mg ml-') and 10% fetal calf serum (Biological Industries, kibbutz beth haemek, Israel; batch 501104 and 785225). All media and supplements were obtained from Gibco, Paisley, UK. Cells were grown in sealed T25 tissue culture flasks containing 5 ml of medium and gassed with a mixture of 95% air-5% carbon dioxide when reseeded. Subculturing occurred weekly (seeded at 5 x 105 cells ml-1) with twice-weekly feeding with complete fresh culture medium.
Survival after ionizing radiation
Cell survival was assessed using a conventional clonogenic survival assay after high-(3.1 Gy min-') or low-(0.112 Gy min-') dose-rate irradiation using a 6OCo-y source (Wilks et al, 1996) . Briefly, cells were irradiated either as single-cell suspensions at room temperature (high dose rate) or cell monolayers in tissue culture flasks at 37°C (low dose rate). In all cases, control (unirradiated) Survival curve analysis Surviving fractions were calculated as described previously (Marples and Joiner, 1993 (Ormerod, 1990) . The ice-cold cell suspension (8 x 104 cells ml-') was irradiated at room temperature and returned immediately to ice to minimize enzymatic DNA dsb repair. A 1-ml aliquot of the ice-cold treated cell suspension was mixed with 2.5 ml of pre-warmed (45°C) 1% agarose (low-gelling-point Analysis of initial and residual damage A minimum of three independent experiments were carried out per cell line. Comets were analysed using a Leitz Diaplan fluorescent microscope at 200x magnification using a Kinetic Imaging Komet system (Liverpool, UK) (Ashby et al, 1995) . Tail moment was used as an index of DNA damage, which combines a measure of the length of the comet tail and the proportion of DNA to migrate into the tail (Olive and Banaith, 1993 Flow cytometry Immediately before each experiment an aliquot of the cell population was washed twice in phosphate-buffered saline (PBS) and resuspended in 0.5 ml of PBS and fixed with 4.5 ml of ice-cold 70% ethanol (in PBS) for a minimum of 24 h at 4°C.
Subsequently, the cells were washed twice in PBS, pelleted and resuspended in 800 gl of PBS, 100 ,l of RNAase (1 mg ml') and 100 ,l of propidium iodide (1 mg ml-') for 30 min at 37°C (Ormerod, 1990) . Analysis of cell cycle phase distributions were carried out on a Becton Dickinson FACScan flow cytometer at 488 nm using a long-pass filter.
RESULTS
The radiation survival curve parameters after high-(HDR) and low-dose-rate (LDR) irradiation for the seven cell lines used are given in Table 1 , and the data are illustrated in Figure 1 . The data Table 1 Parameters from the linear quadratic model fitted to the survival data in Figure 1 and points for HDR irradiation represent the mean survival (± standard deviation) calculated from a minimum of three independent experiments (n = 3-12) with three to six replicate dose measurements; survival after LDR irradiation was calculated from two or three independent experiments. A range of cellular radiosensitivity was seen, with the SF2 values differing by a factor of 2.8 (range 0.31-0.87) after HDR irradiation and by a factor of 2.3 (range 0.38-0.87) after LDR radiation treatment. Figure 2 shows the initial and residual DNA dsb dose-response curves obtained from the three individual experiments for two of the tumour cell lines used. Linear dose-response curves were evident in each experiment for initial and residual damage. A linear relationship between dose and initial and residual DNA dsbs was also seen in the majority of the individual experiments for the other five cell lines, albeit with greater variability (correlation coefficients >0.74) (data not shown). In all experiments, the influence of cell age on assay variability was minimized by using confluent cultures to reduce the proportion of cells in S-phase, as the presence of replication forks in DNA can restrict migration under electrophoresis (Olive et al, 1992; . In each experiment, flow cytometry analysis indicated that the proportion of cells in the S-phase of the cell cycle was always below 18% (range 7-17%, mean 12%), irrespective of the cell line used.
The combined initial and residual DNA dsb dose-response curves compiled from the data of the individual experiments for all seven cell lines are shown in were steeper than those for residual damage. The shallower residual damage slopes indicate that there were fewer DNA dsbs after a 16-h incubation at 37°C ( Table 2 ). The slopes of the fitted linear regression to the residual DNA dsb dose-response curves varied by a factor of 3.6 (range 0.16-0.58). The ratio of the slopes of the initial and the residual dose-response curves, representing the fraction of DNA damage unrepaired, varied by a factor of 2.1 (range 0.47-0.99).
A comparison was made of the relationship between clonogenic survival after HDR and LDR irradiation and the level of radiationinduced DNA dsbs measured using the neutral comet assay. No relationship was found between HDR SF2 and the slopes of initial (P = 0.91) or residual (P = 0.23) DNA dsb dose-response curves fitted by linear regression. In contrast, an association was evident between HDR SF2 and the ratio of the number of initial and residual DNA dsbs (i.e. the fraction of DNA damage unrepaired) after a 60-Gy dose of radiation (r = 0.58; P = 0.17) ( Figure 4B ). Moreover, a statistically Figure 4A ). Stronger correlations were found between SF2 after low-dose-rate irradiation and the fraction of DNA damage unrepaired (ratio of initial and residual damage) at 60 Gy (r = 0.78; P = 0.09) and over the complete dose range studied (r = -0.86; P = 0.03) (Figure 4C and D) .
DISCUSSION
Evidence that the radiosensitivity of a tumour is an important factor involved in determining patient response to radiotherapy has been gained from work carried out using clonogenic assays (West, 1995; West et al, 1997) . These assays are however too laborious for routine clinical application, and this has stimulated an interest in the development of more rapid measures of radiosensitivity. The comet assay is attractive as a potential clinical test of tumour radiosensitivity as it requires few cells and generates results rapidly compared with standard clonogenic and other electrophoresis assays.
The linear relationship between the production of radiationinduced DNA dsbs and dose shown in Figures 2 and 3 is in good agreement with previous studies using a variety of DNA dsb assays (reviewed by Nuniiez, 1996) and the neutral comet assay (Olive et al, 1994) . In the present study, a comparison of the slopes obtained from the linear regression analysis of the initial DNA dsb dose-response curves for the seven tumour lines showed significant variation, indicating different levels of initial damage between the different cell lines (Figure 3 and Table 2 ). The present finding agrees with other studies that have shown significant differences in DNA dsb induction between human tumour cells lines using neutral elution (Kelland et al, 1988) or pulsed-field gel electrophoresis (Whitaker et al, 1995) . However, the results from Figure  3 contrast with the data of Olive et al (1994) using the neutral comet assay which showed no significant differences in radiationinduced DNA dsb in a range of six histologically distinct human tumour cell lines (melanoma, prostate carcinoma, glioma, colon adenocarcinoma and cervical carcinoma).
In order to have confidence in the potential use of a rapid assay of tumour radiosensitivity, correlations must be shown with clonogenic measures of radiosensitivity. A significant correlation has been reported previously between clonogenic radiosensitivity and the levels of initial radiation-induced damage in human tumour cells (Kelland et al, 1988; Nuniiez et al, 1996) . It was postulated that this might reflect differences in the number of lesions incurred by the radiosensitive cells compared with the resistant cells, as shown by Peacock et al (1989) , or possibly differences in chromatin conformation that affect the accessibility of scavenging molecules to damaged DNA or radical attack (Oleinick et al, 1984; Olive et al, 1992) or the 'presentation' of DNA damage sites (Woudstra et al, 1996) . However, the results from this study indicate that in the cervical tumour lines studied here the level of initial DNA damage does not correspond with clonogenic radiosensitivity after HDR and LDR irradiation (Table 3) .
In contrast, Ward (1990) argued that the yield of molecular lesions (initial damage) is independent of tumour cell type and that radiation-sensitive cells are repair deficient, resulting in different levels of residual damage. However, in our work, there were no significant differences in the slopes of the residual DNA dsb dose-response curves fitted by linear regression and SF2 after HDR and LDR irradiation. Nevertheless other human tumour studies measuring DNA dsbs by asymmetric field-inversion gel electrophoresis (Giaccia et al, 1992) and neutral filter elution (Zaffaroni et al, 1994) have indeed shown significant correlations between the level of residual dsbs and radiosensitivity.
A new finding in the present studies was the significant correlation with the extent of dsb repair (ratio of initial and residual slopes) after 16 h of post-irradiation incubation and radiosensitivity after HDR (r = -0.78, P = 0.04) or LDR (r = -0.86, P = 0.03) irradiation (Figure 4) . DNA dsb repair measured using the neutral comet assay and cellular radiosensitivity were found not to correlate in a study by Olive et al (1992) , however one possible explanation for the difference between the present study and that of Olive et al (1992) may reflect the time interval allowed for repair: 4 h in the previous study and 16 h in the present study. It has been noted that measuring residual DNA dsbs using the neutral comet assay at 4 h may underestimate the level of DNA damage as a result of the increase in the percentage of S-phase cells after irradiation, as S-phase DNA migrates inefficiently. This would not be expected in the present study using a 16 h period of repair (Olive et al, 1994) .
In support of the correlation between SF2 and repair capacity reported here, a non-significant trend was evident between LDR SF2 and the absolute difference in residual and initial DNA dsbs assessed from a single dose of 60 Gy (P = 0.09) and a significant trend over the complete dose range studied (P = 0.03) (Figure 4B and D). The stronger relationship between the level of DNA dsbs and SF2 measured after LDR irradiation is not unexpected and reflects the potential of each cell line to repair radiation-induced DNA dsbs during exposure. A correlation between radiosensitivity and level of dsbs in four histologically related tumour cell lines has been reported previously after low-dose-rate but not at highdose-rate irradiation using PGFE (Cassoni et al, 1992) .
The approach of examining the unrepaired DNA dsb fraction by taking a ratio of dose-response curve slopes (thereby assessing damage from a range of multiple dose points) minimizes variability between experiments on the different cell lines and suggests that it is only by doing so that a significant correlation can be seen between HDR SF2 and DNA dsb repair capacity as measured by the neutral comet assay. Recently, we have also found a strong correlation between the ratio of slopes of initial/residual DNA dsb dose-response curves and radiosensitivity after HDR irradiation for nine normal fibroblast strains derived from vaginal biopsies from pretreatment cancer patients (r = 0.80, P = 0.01) . It is not clear yet whether the importance of the unrepaired fraction of DNA dsbs is related to, for example, DNA ploidy, possible influence of chromatin structure/DNA organization on the translation of residual DNA damage into potentially lethal events or on the tolerance of cells to genetic injury. Alternatively, assessing repair capacity by the ratio of damage (initial/residual) may relate to misrepair of radiation-induced DNA dsbs. Such possibilities will require further investigation.
A review of the literature (see Introduction) illustrates the disparate findings over the possible relationship between DNA dsb damage and clonogenic measures of radiosensitivity. There is clearly some relationship but the question of interest is which parameter is the most important component (initial or residual damage, ratio of damage, rate of repair, time at which repair is assayed, etc.). The balance of evidence suggests that residual damage is likely to be the most critical aspect but, in view of the published data, the significance of initial damage cannot yet be discounted. The divergent results may relate to differences in the assays used to score DNA dsb damage and/or experimental design (e.g. selection and number of cell lines, doses used, time allowed for repair). In an attempt to overcome some of the limitations of other studies, we have selected a large series of cell lines of the same histological origin (seven human cervical carcinoma cell lines) and have assessed both initial and residual DNA damage over a range of radiation doses. In doing so, we have demonstrated a significant relationship between the ratio of initial and residual radiation-induced DNA dsbs, measured using the neutral comet assay, and cellular radiosensitivity measured using a clonogenic assay. It is likely that the continued improvements of assay conditions may improve this further, e.g. more sensitive DNA-binding dyes, more optimal lysing conditions. The work supports the continued use of the neutral comet assay as a potential rapid predictive test for tumour radiosensitivity in radiotherapy.
